Search
Idaverine
go.drugbank.com/drugs/DB21246ExperimentalThe usage of the INN stem '-verine' in the name indicates that Idaverine is a spasmolytic with a papaverine-like action. Idaverine has a monoisotopic molecular weight of 417.3 Da.
Niceverine
go.drugbank.com/drugs/DB21250ExperimentalThe usage of the INN stem '-verine' in the name indicates that Niceverine is a spasmolytic with a papaverine-like action. Niceverine has a monoisotopic molecular weight of 521.16 Da.
Domazoline
go.drugbank.com/drugs/DB19937ExperimentalThe usage of the INN stem '-azoline' in the name indicates that Domazoline is a antihistaminic or local vasoconstrictor, antazoline derivative.
Propinetidine
go.drugbank.com/drugs/DB20164ExperimentalThe usage of the INN stem '-tidine' in the name indicates that Propinetidine is a histamine- H2-receptor antagonist, cimetidine derivative.
CMLVAX100
go.drugbank.com/drugs/DB05164ExperimentalCMLVAX100 is a vaccine targeting the BCR-ABL-derived p210 fusion protein which reduces residual disease in some patients with chronic myeloid leukemia.
Mosedipimod
go.drugbank.com/drugs/DB12592InvestigationalMosedipimod has been used in trials studying the supportive care and treatment of Chemotherapy-induced Neutropenia.
R1204
go.drugbank.com/drugs/DB05118ExperimentalR1204 is G-protein-coupled receptor modulator. It is developed for the treatment of depression.
Flurocitabine
go.drugbank.com/drugs/DB20317ExperimentalThe usage of the INN stem '-citabine' in the name indicates that Flurocitabine is a nucleoside antiviral or antineoplastic agent, cytarabine or azacitidine derivative.
Metergoline
go.drugbank.com/drugs/DB13520Approved[A27181] Its use has been studied in various clinical settings such as a treatment for seasonal affective disorder, prolactin hormone regulation due to its inhibitory effect on prolactin release,[A27182 … Metergoline is an antagonist at various 5-HT receptor subtypes at a relatively low concentration and agonist at dopamine receptors.
Categories: Serotonin Receptor Agonists, Serotonin Receptor AntagonistsSARS-CoV-2 Sclamp
go.drugbank.com/drugs/DB15849InvestigationalTetraQ, Australian National University (ANU), the University of Melbourne, and the Peter Doherty Institute for Infection and Immunity are also involved in the clinical component. … Preclinical trials showed the vaccine candidate produced high levels of neutralizing antibodies, and induced a strong T-cell response.